| 12 Mon |
|---|
|
All-day
|
|
12:00 am
1:00 am
2:00 am
3:00 am
4:00 am
5:00 am
6:00 am
7:00 am
8:00 am
9:00 am
10:00 am
11:00 am
12:00 pm
1:00 pm
2:00 pm
3:00 pm
4:00 pm
5:00 pm
6:00 pm
7:00 pm
8:00 pm
9:00 pm
10:00 pm
11:00 pm
10:35 am
Invited Talk : Preclinical Outsourcing to India
@ Sathyam Hall
Invited Talk : Preclinical Outsourcing to India
@ Sathyam Hall
Aug 12 @ 10:35 am – 11:00 am
 Ganesh Sambasivam, Ph.D. CSO & Co-Founder, Anthem Biosciences India Preclinical Outsourcing to India The outsourcing segment is witnessing rapid changes with respect to the nature of work outsourced and the location. Cost is the major driver but other considerations such
11:27 am
Invited Talk: A Far- Western Clinical Proteomics Approach to Detect Molecules of Clinical and Pathological Significance in the Neurodegenerative Disease Multiple Sclerosis
@ Amriteshwari Hall
Invited Talk: A Far- Western Clinical Proteomics Approach to Detect Molecules of Clinical and Pathological Significance in the Neurodegenerative Disease Multiple Sclerosis
@ Amriteshwari Hall
Aug 12 @ 11:27 am – 11:50 am
 Krishnakumar Menon, Ph.D. Associate Professor, Centre for Nanosciences & Molecular Medicine, Amrita University, Kochi, India A Far-Western Clinical Proteomics Approach to Detect Molecules of Clinical and Pathological Significance in the Neurodegenerative Disease Multiple Sclerosis. Multiple Sclerosis (MS), an autoimmune neurodegenerative
1:30 pm
Plenary Address: A novel strategy for targeting metalloproteinases in cancer
@ Acharya Hall
Plenary Address: A novel strategy for targeting metalloproteinases in cancer
@ Acharya Hall
Aug 12 @ 1:30 pm – 2:00 pm
 Gillian Murphy, Ph.D. Professor, Department of Oncology, University of Cambridge, UK A novel strategy for targeting metalloproteinases in cancer Epithelial tumours evolve in a multi-step manner, involving both inflammatory and mesenchymal cells. Although intrinsic factors drive malignant progression, the influence
|
Subscribe to filtered calendar